SARS-CoV-2 vaccination in IBD: more pros than cons
- 20 January 2021
- journal article
- editorial
- Published by Springer Science and Business Media LLC in Nature Reviews Gastroenterology & Hepatology
- Vol. 18 (4), 211-213
- https://doi.org/10.1038/s41575-021-00420-w
Abstract
Data on the efficacy and safety of SARS-CoV-2 vaccines are now available, but evidence for these vaccines in those who are immunocompromised (including patients with inflammatory bowel diseases) are lacking. As vaccination begins, questions on advantages and disadvantages can be partially addressed using the experience from other vaccines or immune-mediated inflammatory disorders.This publication has 10 references indexed in Scilit:
- Winter Is Coming! Clinical, Immunologic, and Practical Considerations for Vaccinating Patients With Inflammatory Bowel Disease During the Coronavirus Disease-2019 PandemicGastroenterology, 2021
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 VaccineThe New England Journal of Medicine, 2020
- Evolution of Early SARS-CoV-2 and Cross-Coronavirus ImmunitymSphere, 2020
- Systematic Review on Inflammatory Bowel Disease Patients With Coronavirus Disease 2019: It Is Time to Take StockClinical Gastroenterology and Hepatology, 2020
- Environmental Risk Factors for Inflammatory Bowel Diseases: An Umbrella Review of Meta-analysesGastroenterology, 2019
- The effect of tofacitinib on pneumococcal and influenza vaccine responses in rheumatoid arthritisAnnals Of The Rheumatic Diseases, 2015
- Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel diseaseJournal of Crohn's and Colitis, 2014
- Effects of immunosuppression on immune response to pneumococcal vaccine in inflammatory bowel disease: A prospective study*Inflammatory Bowel Diseases, 2012
- H1N1 vaccines in a large observational cohort of patients with inflammatory bowel disease treated with immunomodulators and biological therapyGut, 2011
- Immune Response to Influenza Vaccine in Pediatric Patients With Inflammatory Bowel DiseaseClinical Gastroenterology and Hepatology, 2007